Literature DB >> 11254669

Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease.

M M Kosiewicz1, C C Nast, A Krishnan, J Rivera-Nieves, C A Moskaluk, S Matsumoto, K Kozaiwa, F Cominelli.   

Abstract

We describe here the immunologic characterization of a new mouse strain, SAMP1/Yit, which spontaneously develops a chronic intestinal inflammation localized to the terminal ileum. The resulting ileitis bears a remarkable resemblance to human Crohn's disease. This strain of mice develops discontinuous, transmural inflammatory lesions in the terminal ileum with 100% penetrance by 30 weeks of age. The intestinal inflammation is characterized by massive infiltration of activated CD4+ and CD8alpha(+)TCRalphabeta(+) T cells into the lamina propria and is accompanied by a dramatic decrease in the intraepithelial lymphocyte CD8alpha(+)TCRgammadelta(+)/CD8alpha(+)TCRalphabeta(+) ratio. The results of adoptive transfer experiments strongly suggest that CD4+ T cells that produce a Th1-like profile of cytokines, e.g., IFN-gamma and TNF, mediate the intestinal inflammation found in SAMP1/Yit mice. In addition, pretreatment of adoptive transfer recipients with a neutralizing anti-TNF antibody prevents the development of intestinal inflammation, suggesting that TNF plays an important role in the pathogenesis of intestinal inflammation in this model. To our knowledge, these data provide the first direct evidence that Th1-producing T cells mediate intestinal inflammation in a spontaneous animal model of human Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254669      PMCID: PMC208944          DOI: 10.1172/JCI10956

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

Review 1.  Genetics of inflammatory bowel disease. A personal view on progress and prospects.

Authors:  J Satsangi; D Jewell; M Parkes; J Bell
Journal:  Dig Dis       Date:  1998 Nov-Dec       Impact factor: 2.404

2.  Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora.

Authors:  S L Brandwein; R P McCabe; Y Cong; K B Waites; B U Ridwan; P A Dean; T Ohkusa; E H Birkenmeier; J P Sundberg; C O Elson
Journal:  J Immunol       Date:  1997-07-01       Impact factor: 5.422

3.  Alteration of a polyclonal to an oligoclonal immune response to cecal aerobic bacterial antigens in TCR alpha mutant mice with inflammatory bowel disease.

Authors:  A Mizoguchi; E Mizoguchi; S Tonegawa; A K Bhan
Journal:  Int Immunol       Date:  1996-09       Impact factor: 4.823

4.  Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.

Authors:  J Satsangi; K I Welsh; M Bunce; C Julier; J M Farrant; J I Bell; D P Jewell
Journal:  Lancet       Date:  1996-05-04       Impact factor: 79.321

5.  Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.

Authors:  R Duchmann; E Schmitt; P Knolle; K H Meyer zum Büschenfelde; M Neurath
Journal:  Eur J Immunol       Date:  1996-04       Impact factor: 5.532

Review 6.  The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.

Authors:  G Kollias; E Douni; G Kassiotis; D Kontoyiannis
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

7.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

8.  Gut-homing CD4+ T cell receptor alpha beta+ T cells in the pathogenesis of murine inflammatory bowel disease.

Authors:  A Rudolphi; G Boll; S S Poulsen; M H Claesson; J Reimann
Journal:  Eur J Immunol       Date:  1994-11       Impact factor: 5.532

9.  Activation of CD4+ T lymphocytes form interleukin 2-deficient mice by costimulatory B7 molecules.

Authors:  Z Razi-Wolf; G A Höllander; H Reiser
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

10.  Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.

Authors:  F Powrie; R Correa-Oliveira; S Mauze; R L Coffman
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more
  80 in total

Review 1.  The SAMP1/Yit mouse: another step closer to modeling human inflammatory bowel disease.

Authors:  W Strober; K Nakamura; A Kitani
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

Review 2.  Tumour necrosis factor in mouse models of chronic intestinal inflammation.

Authors:  Christoph Mueller
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

3.  Beta7 integrin deficiency suppresses B cell homing and attenuates chronic ileitis in SAMP1/YitFc mice.

Authors:  Gezahegn Gorfu; Jesus Rivera-Nieves; Sharon Hoang; Derek W Abbott; Keely Arbenz-Smith; David W Azar; Theresa T Pizarro; Fabio Cominelli; Marcia McDuffie; Klaus Ley
Journal:  J Immunol       Date:  2010-10-06       Impact factor: 5.422

4.  Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon.

Authors:  D Berrebi; R Maudinas; J-P Hugot; M Chamaillard; F Chareyre; P De Lagausie; C Yang; P Desreumaux; M Giovannini; J-P Cézard; H Zouali; D Emilie; M Peuchmaur
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

Review 5.  Averting inflammation by targeting the cytokine environment.

Authors:  Manfred Kopf; Martin F Bachmann; Benjamin J Marsland
Journal:  Nat Rev Drug Discov       Date:  2010-09       Impact factor: 84.694

Review 6.  Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases.

Authors:  Mei Lan Chen; Mark S Sundrud
Journal:  Inflamm Bowel Dis       Date:  2016-05       Impact factor: 5.325

7.  In vivo demonstration of T lymphocyte migration and amelioration of ileitis in intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM-1.

Authors:  K Matsuzaki; Y Tsuzuki; H Matsunaga; T Inoue; J Miyazaki; R Hokari; Y Okada; A Kawaguchi; S Nagao; K Itoh; S Matsumoto; S Miura
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

Review 8.  Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease.

Authors:  D S A Sanders
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

9.  Role of interleukin 6 in a murine model of Crohn's ileitis: are cytokine/anticytokine strategies the future for IBD therapies?

Authors:  T T Pizarro; S A De La Rue; F Cominelli
Journal:  Gut       Date:  2006-09       Impact factor: 23.059

10.  Acute appendicitis is characterized by a uniform and highly selective pattern of inflammatory gene expression.

Authors:  C G Murphy; J N Glickman; K Tomczak; Y Y Wang; A H Beggs; M W Shannon; B H Horwitz
Journal:  Mucosal Immunol       Date:  2008-07       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.